<prompt> Answer this question truthfullyWhat is the recommended medical treatment for acute lymphoblastic leukemia?  <response>: <reason> Treatment with chemotherapeutic drugs e.g., prednisone plus vincristine plus cyclophosphamide plus doxorubicin; methotrexate plus 6-MP to prevent disease recurrence once remission has been achieved Maintenance therapy usually involves drug doses that are lower than those administered during the induction phase In children, an intensive 6-month treatment program is needed after induction, followed by 2 years of maintenance chemotherapy During maintenance therapy, patients are at risk for infection. Fever in children who are receiving chemotherapy must be assesed and treated enthusiatically, especially for patients who are either neutropenic or have a central venous access device.The following drugs are given: Trimethoprim-sulfamethoxazole Dapsone Pentamidine, or Atovaquoneprophylaxis is continued to prevent Pneumocystis pneumoniaTreatment is administered on an outpatient basis, and typically is known to cause less toxicity 1.1 Pediatric Preferred regimen1: Vincristine 1.5 mgm2dose IV. Given every 4 weeks Preferred regimen2: Prednisone 40 mgm2day PO. It is given in 2 divided doses on days 0 to 13 Preferred regimen1: Methotrexate 20 mgm2 once weekly, given PO Preferred regimen5: Doxorubacin 30 mgm2dose, given IV. Its is given on days 0 and 1 of a 4-week cycle Preferred regimen 6: Cyclophosphamide 1 to 5 mgkgday PO Preferred regimen6: Mercaptopurine 75 mgm2 once daily on days 1 to 84 of an 84-day cycle, given PO1.1 Adult Preferred regimen1: Vincristine 2 mgm2dose IV. Given every 4 weeks Preferred regimen2: Prednisone 40 mgm2day PO. It is given in 2 divided doses on days 0 to 13 Preferred regimen1: Methotrexate 10 mgm2day IV for 5 days every month for 2 years Preferred regimen5: Doxorubacin 30 mgm2dose, given IV. Its is given on days 0 and 1 of a 4-week cycle Preferred regimen 6: Cyclophosphamide 1 to 5 mgkgday PO Preferred regimen6: Mercaptopurine 50 mg 3 timesday for 2 years, given PO 